6 results
The primary study objective is to assess whether CML patients who respond to treatment with nilotinib (MMR within 12 months of treatment) differ from the non-responders in terms of adherence. Secondary objective is to evaluate whether responders and…
Primary Objective: *How do parents experience and perceive EOL decision-making after allogeneic paediatric SCT?* Secondary Objectives: - How do parents gain insight in their child*s condition and treatment options during EOL process?- With which EOL…
Primary objective: To develop and validate a DBS sampling method of nilotinib for TDM purposes. Secondary objectives: To get insight into normal trough plasma levels and the use of the DBSM.
In preparation of a larger RCT we aim to conduct a pilot study which investigates the feasibility of the described physical exercise program and its effects. Purpose of this study is to develop this exercise program, to test the implementation and…
This study has been transitioned to CTIS with ID 2024-514588-24-00 check the CTIS register for the current data. Core Primary Objectives:1. To investigate the safety and tolerability of EP0042 given alone or in combination with anti-cancer…
Primary Objective:- To assess and describe Quality of Life throughout a patients treatment trajectorySecondary Objective(s):- To assess and describe how frail unselected real world AML patients are at diagnosis using geriatric screening tools (G8, 6…